Literature DB >> 25638532

Evolving brain structural changes in PSEN1 mutation carriers.

Roser Sala-Llonch1, Albert Lladó2, Juan Fortea3, Beatriz Bosch2, Anna Antonell2, Mircea Balasa2, Nuria Bargalló4, David Bartrés-Faz1, José Luis Molinuevo2, Raquel Sánchez-Valle5.   

Abstract

Familial Alzheimer's disease provides the opportunity to investigate brain changes even before the symptoms onset. We performed a structural magnetic resonance imaging (MRI) study in 38 participants from families with presenilin 1 gene mutations: 11 symptomatic mutation carriers, 13 asymptomatic mutation carriers (AMC), with a mean of 16.22 years before the estimated appearance of symptoms, and 14 noncarriers. A subset of subjects was studied longitudinally 2 and 4 years after the first scan. We found decreased cortical thickness (CTh) and volume in cortical and subcortical structures in symptomatic mutation carriers, with progressive loss over time. In AMC, we found increased CTh and volume in temporoparietal regions and in precuneus-posterior cingulate compared with controls at baseline. Longitudinal studies in AMC, by contrast, showed accelerated rates of CTh loss in precuneus-posterior cingulate and superior parietal, right lateral temporal and left orbitofrontal, and middle frontal regions. These findings suggest that brain structure in presenilin 1 mutation carriers follows nonlinear trajectories, with regional increases during the very early presymptomatic period. Initial neuroinflammation and/or accumulation of amyloid species followed by neurodegeneration, or congenital morphometric differences, may explain the observed features.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Biomarkers; Cortical thickness; Presenilin 1; Presymptomatic

Mesh:

Substances:

Year:  2014        PMID: 25638532     DOI: 10.1016/j.neurobiolaging.2014.12.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial magnetic resonance imaging study.

Authors:  Kirsi M Kinnunen; David M Cash; Teresa Poole; Chris Frost; Tammie L S Benzinger; R Laila Ahsan; Kelvin K Leung; M Jorge Cardoso; Marc Modat; Ian B Malone; John C Morris; Randall J Bateman; Daniel S Marcus; Alison Goate; Stephen P Salloway; Stephen Correia; Reisa A Sperling; Jasmeer P Chhatwal; Richard P Mayeux; Adam M Brickman; Ralph N Martins; Martin R Farlow; Bernardino Ghetti; Andrew J Saykin; Clifford R Jack; Peter R Schofield; Eric McDade; Michael W Weiner; John M Ringman; Paul M Thompson; Colin L Masters; Christopher C Rowe; Martin N Rossor; Sebastien Ourselin; Nick C Fox
Journal:  Alzheimers Dement       Date:  2017-07-22       Impact factor: 21.566

2.  Is bigger better? Towards a mechanistic understanding of neuropsychiatric symptoms in Alzheimer's disease.

Authors:  Milap A Nowrangi; Paul B Rosenberg
Journal:  Int Psychogeriatr       Date:  2021-09-24       Impact factor: 3.878

3.  Mild Traumatic Brain Injury Results in Significant and Lasting Cortical Demyelination.

Authors:  Sean O Mahoney; Nahian F Chowdhury; Van Ngo; Phoebe Imms; Andrei Irimia
Journal:  Front Neurol       Date:  2022-06-23       Impact factor: 4.086

4.  Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults.

Authors:  Matthew R Scott; Olivia L Hampton; Rachel F Buckley; Jasmeer P Chhatwal; Bernard J Hanseeuw; Heidi Il Jacobs; Michael J Properzi; Justin S Sanchez; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2020-06-05       Impact factor: 6.556

5.  Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.

Authors:  Philip S J Weston; Jennifer M Nicholas; Manja Lehmann; Natalie S Ryan; Yuying Liang; Kirsty Macpherson; Marc Modat; Martin N Rossor; Jonathan M Schott; Sebastien Ourselin; Nick C Fox
Journal:  Neurology       Date:  2016-10-12       Impact factor: 9.910

Review 6.  The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.

Authors:  José Luis Molinuevo; Carolina Minguillon; Lorena Rami; Juan Domingo Gispert
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

7.  Biphasic cortical macro- and microstructural changes in autosomal dominant Alzheimer's disease.

Authors:  Victor Montal; Eduard Vilaplana; Jordi Pegueroles; Alexandre Bejanin; Daniel Alcolea; María Carmona-Iragui; Jordi Clarimón; Johannes Levin; Carlos Cruchaga; Neill R Graff-Radford; James M Noble; Jae-Hong Lee; Ricardo Allegri; Celeste M Karch; Christoph Laske; Peter R Schofield; Stephen Salloway; Beau Ances; Tammie Benzinger; Eric McDale; Randall Bateman; Rafael Blesa; Raquel Sánchez-Valle; Alberto Lleó; Juan Fortea
Journal:  Alzheimers Dement       Date:  2020-11-16       Impact factor: 21.566

8.  Associations between subregional thalamic volume and brain pathology in autosomal dominant Alzheimer's disease.

Authors:  Enmanuelle Pardilla-Delgado; Heirangi Torrico-Teave; Justin S Sanchez; Liliana A Ramirez-Gomez; Ana Baena; Yamile Bocanegra; Clara Vila-Castelar; Joshua T Fox-Fuller; Edmarie Guzmán-Vélez; Jairo Martínez; Sergio Alvarez; Martin Ochoa-Escudero; Francisco Lopera; Yakeel T Quiroz
Journal:  Brain Commun       Date:  2021-05-10

9.  Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.

Authors:  Elena Rodriguez-Vieitez; Laure Saint-Aubert; Stephen F Carter; Ove Almkvist; Karim Farid; Michael Schöll; Konstantinos Chiotis; Steinunn Thordardottir; Caroline Graff; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Brain       Date:  2016-01-26       Impact factor: 13.501

10.  Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study.

Authors:  Brian A Gordon; Tyler M Blazey; Yi Su; Amrita Hari-Raj; Aylin Dincer; Shaney Flores; Jon Christensen; Eric McDade; Guoqiao Wang; Chengjie Xiong; Nigel J Cairns; Jason Hassenstab; Daniel S Marcus; Anne M Fagan; Clifford R Jack; Russ C Hornbeck; Katrina L Paumier; Beau M Ances; Sarah B Berman; Adam M Brickman; David M Cash; Jasmeer P Chhatwal; Stephen Correia; Stefan Förster; Nick C Fox; Neill R Graff-Radford; Christian la Fougère; Johannes Levin; Colin L Masters; Martin N Rossor; Stephen Salloway; Andrew J Saykin; Peter R Schofield; Paul M Thompson; Michael M Weiner; David M Holtzman; Marcus E Raichle; John C Morris; Randall J Bateman; Tammie L S Benzinger
Journal:  Lancet Neurol       Date:  2018-02-01       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.